| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/24/1994 | CN1091134A Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 08/24/1994 | CN1091129A Excitatory amino acid receptor antagonists |
| 08/24/1994 | CN1091006A Compounds useful as hypoglycemic agents and for treating alzheimer's disease |
| 08/23/1994 | US5340832 Prolinal derivatives useful for treating amnesia |
| 08/23/1994 | US5340831 Muscular disorders of alimentary canal, respiratory system |
| 08/23/1994 | US5340824 Anticonvulsant, psychological and nervous sytem disorders |
| 08/23/1994 | US5340810 Benzanilide derivatives |
| 08/23/1994 | US5340809 New 1-(alkoxybenzyl)piperazine amide compounds |
| 08/23/1994 | CA1331625C Unsaturated amino acids |
| 08/23/1994 | CA1331617C Thiazolidine derivatives, process for preparing same and anti-amnestic composition containing same |
| 08/23/1994 | CA1331616C Organic salts of physostigmine derivative |
| 08/23/1994 | CA1331610C Antihypertensive 3-piperidinyl-indazole derivatives |
| 08/23/1994 | CA1331609C Antipsychotic 3-piperazinylbenzazole derivatives |
| 08/23/1994 | CA1331606C Calcium independent camp phosphodiesterase inhibitor antidepressant |
| 08/20/1994 | CA2115805A1 Polysubstituted 2-amino-thiazole derivatives |
| 08/18/1994 | WO1994018215A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
| 08/18/1994 | WO1994018200A1 Novel inhibitors of adenosine monophosphate deaminase |
| 08/18/1994 | WO1994018196A1 Heteroaromatic compounds with antipsychotic activity |
| 08/18/1994 | WO1994018194A1 Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as intiinflammatory agents |
| 08/18/1994 | WO1994018193A1 Novel heterocyclic aminomethyl-4 piperidine derivatives, their preparation and application in therapy |
| 08/18/1994 | WO1994018175A1 Heterocyclic compounds and their preparation and use |
| 08/18/1994 | WO1994018170A1 Use of phenyl heteroaryl ureas as 5ht2c receptor antagonists and urea compounds |
| 08/18/1994 | WO1994017831A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/18/1994 | WO1994017822A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
| 08/18/1994 | WO1994017821A1 Use of thrombine inhibitors for controlling neurodegenerative diseases |
| 08/18/1994 | WO1994017802A1 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents |
| 08/18/1994 | WO1994017801A1 Pharmaceutical compositions comprising cyclodextrin inclusion complexes of the compound ci-979 |
| 08/18/1994 | WO1994017795A1 Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease |
| 08/18/1994 | WO1994017790A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
| 08/18/1994 | CA2155849A1 New heterocyclic derivatives of 4-aminomethyl piperidine; process for preparing the same and their use as therapeutic agents |
| 08/18/1994 | CA2155758A1 Heteroaromatic compounds with antipsychotic activity |
| 08/18/1994 | CA2155355A1 Heterocyclic compounds and their preparation and use |
| 08/18/1994 | CA2154681A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
| 08/18/1994 | CA2153420A1 The use of thrombin inhibitors for controlling neurodegenerative disorders |
| 08/18/1994 | CA2152796A1 Use of inhibitors of ornithine aminotransferase for the manufacture of medicament for the treatment of alzheimer's disease |
| 08/18/1994 | CA2150373A1 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents |
| 08/18/1994 | CA2150135A1 Pharmaceutical compositions comprising cyclodextrin inclusion complexes of the compound ci-979 |
| 08/18/1994 | CA2117889A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/17/1994 | EP0610697A1 Imidazole substituted phenylaceticacidprolinzamide derivatives |
| 08/17/1994 | EP0610655A1 Medicament containing dexpanthenol for topical application |
| 08/17/1994 | EP0610595A2 Composition of l-dopa esters |
| 08/17/1994 | EP0610475A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 08/17/1994 | EP0610336A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 08/17/1994 | EP0610303A1 Substituted dibenzoxazepine compounds as analgesic agents |
| 08/17/1994 | EP0610254A1 Glial derived neurotrophic factor |
| 08/17/1994 | EP0610192A1 Ether derivatives of alkyl piperidines and pyrrolidines as antipsychotic agents |
| 08/17/1994 | CN1090776A Method for the safe administration of fatty acids |
| 08/17/1994 | CN1090757A Method for the safe administration of fatty acids |
| 08/16/1994 | US5338851 Synthesis of cis-decahydroisoquinoline-3-carboxylic acids |
| 08/16/1994 | US5338760 Treatment of nervous system and gastrointestinal disorders |
| 08/16/1994 | US5338754 Treating stroke or central nervous system disorders |
| 08/16/1994 | US5338753 (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics |
| 08/16/1994 | US5338744 Angiotensin II antagonists used to treat reproductive functions associated with AT2 receptors |
| 08/16/1994 | US5338739 (Pyrrolidinyl)phenyl carbamates, compositions and use |
| 08/16/1994 | US5338735 Pharmaceutical compounds |
| 08/16/1994 | US5338668 Opioid peptides derived from wheat proteins |
| 08/16/1994 | US5338663 Interferes with formation of specific complex between alpha-antichymotrypsin and beta-protein; hydrolysis of substrate does not occur |
| 08/16/1994 | CA2115631A1 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them |
| 08/16/1994 | CA1331459C Sulfonyldecahydro-8h-isoquino-¬2,1-g|¬1,6|- naphthyridines, optical isomers thereof and related compounds |
| 08/10/1994 | EP0633251A4 Derivatives of 9-aminoacridine having psychotropic, antiamnestic and lipid regulating properties. |
| 08/10/1994 | EP0610140A1 2- 4-(4-Azolylbutyl)-1-piperazinyl -5-hydroxypyrimidin derivatives, their preparation and their use als medicines |
| 08/10/1994 | EP0610134A1 Indole, indazole and benzisoxazole derivatives as 5-HT1-like agonists |
| 08/10/1994 | EP0609961A1 Sustained release pharmaceutical composition |
| 08/10/1994 | EP0609630A1 Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease |
| 08/10/1994 | EP0609441A1 Oxazolidone derivative |
| 08/10/1994 | EP0609375A1 Novel 2,6-disubstituted purine derivatives |
| 08/10/1994 | EP0609306A1 Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
| 08/10/1994 | EP0609210A1 OPTICALLY ACTIVE 5H-PYRROLO 3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME. |
| 08/10/1994 | EP0564561A4 Peptides ketoamides, ketoacids, and ketoesters |
| 08/09/1994 | US5336781 Aminating sulfonated indole derivatives |
| 08/09/1994 | US5336769 Xanthine derivatives |
| 08/09/1994 | US5336691 Composition comprising a tramadol material and acetaminophen and its use |
| 08/09/1994 | US5336686 17 Methylene lactones of steroids |
| 08/09/1994 | US5336675 Administering acetylcholinesterase inhibitor which can pass through blood-brain barrier in humans |
| 08/06/1994 | CA2115016A1 Derivatives of 2-(4-4-azolylbutyl)-1-piperazinyl-5-hydroxy pyrimidine, their preparation and their application as medications |
| 08/06/1994 | CA2088878A1 Cdnas encoding the gastrin and cck-b receptors |
| 08/04/1994 | WO1994017061A1 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 08/04/1994 | WO1994017045A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
| 08/04/1994 | WO1994016718A1 Genetic modification of neural stem cells |
| 08/04/1994 | WO1994016709A2 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 08/04/1994 | WO1994016708A1 Pharmaceutical composition for treating nicotine dependence |
| 08/04/1994 | WO1994016705A2 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
| 08/04/1994 | WO1994016699A1 Compositions containing tandospirone or its analogs |
| 08/04/1994 | WO1994016694A1 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| 08/04/1994 | WO1994016689A1 Analgesic medicinal composition |
| 08/04/1994 | WO1994013658A3 Benzocycloheptenes, benzoxepines and benzothiepines |
| 08/04/1994 | CA2154569A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
| 08/04/1994 | CA2154455A1 Analgesic composition |
| 08/04/1994 | CA2152673A1 Compositions containing tandospirone or its analogs |
| 08/03/1994 | EP0609064A1 Use of fatty acids for treatment of internal radiation damage |
| 08/03/1994 | EP0609001A2 Triglycerides |
| 08/03/1994 | EP0608893A1 Inhibiting the development of tolerance to and/or dependence on an additive substance |
| 08/03/1994 | EP0608759A2 Piperazinderivatives |
| 08/03/1994 | EP0608709A1 2-Oxo-quinolin-1-yl-methyl-phenylacetic acid derivatives as angiotensin II Antagonists |
| 08/03/1994 | EP0608671A1 Use of 3-indolepyruvic acid to reduce the level of glucocorticoids in the blood and to prevent cerebral disturbances |
| 08/03/1994 | EP0608353A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES. |
| 08/03/1994 | EP0608336A1 Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
| 08/03/1994 | EP0532602B1 Benzothiazoline derivatives, process for their preparation and drugs containing same |
| 08/03/1994 | CN1090289A Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 08/02/1994 | US5334757 Blocking; deblocking; hydrolysis; esterification; oxidation |